Nicotine inhibits hippocampal and striatal acetylcholinesterase activities, and demonstrates dual action on adult neuronal proliferation and maturation

Pathophysiology

Volumn 22, Issue 4, 2015, Pages 231-239

  Ijomone, Omamuyovwi M ^a,b   Nwoha, Polycarp U ^b  

^a CROSS RIVER UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Acetylcholinesterase; Adult neurogenesis; Cholinergic neurotransmission; Neurogenic markers; Nicotine

Indexed keywords

ACETYLCHOLINESTERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NERVE CELL ADHESION MOLECULE; NEURON SPECIFIC ENOLASE; NICOTINE;

ADULT; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CAUDATE NUCLEUS; CERVICAL SPINE DISLOCATION; CHEMICAL ANALYSIS; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORPUS STRIATUM; DENTATE GYRUS; DESENSITIZATION; ENZYME INHIBITION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE;

EID: 84960230750     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2015.09.002     Document Type: Article

References (39)

1. Tariq M., Khan H.A., Al Deeb S., Al Moutaery K. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Brain Res. Bull. 2005, 67:161-168.
2. Barik J., Wonnacott S. Molecular and cellular mechanisms of action of nicotine in the CNS. Nicotine Psychopharmacology, Handbook of Experimental Pharmacology 2009, 2012:173-207. Springer-Verlag, Berlin Heidelberg.
3. Toyoshi U. Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice. Int. Sch. Res. Net (ISRN) Pharm. 2012, Article ID 170981.
4. Yu W., Mechawar N., Krantic S., Quirion R. α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signalling. J. Neurochem. 2011, 119:848-858.
5. Henningfield J.E., Zeller M. Nicotine psychopharmacology: policy and regulatory. Handbook Exp. Pharmacol. 2009, 192:511-534.
6. Liu Q., Zhao B. Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br. J. Pharmacol. 2004, 141:746-754.
7. Uzum G., Bahcekapili N., Diler A.S., Ziylan Y.Z. Tolerance to pentylentetrazol-induced convulsions and protection of cerebrovascular integrity by chronic nicotine. Int. J. Neurosci. 2004, 114:735-748.
8. Mudo G., Belluardo N., Fuxe K. Nicotinic receptor agonists as neuroprotective/ neurotrophic drug; progress in molecular mechanisms. J. Neural. Transm. 2007, 114:135-147.
9. O'Neill M.J., Murray T.K., Lakics V., Visanji N.P., Duty S. The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. Curr Drug Targets CNS Neurol. Disord. 2002, 1:399-411.
10. Campbell N.R., Fernandes C.C., John D., Lozada A.F., Berg D.K. Nicotinic control of adult-born neuron fate. Biochem. Pharmacol. 2011, 82:820-827.
11. Kuruba R., Hattiangady B., Shetty A.K. Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy. Epilepsy Behav. 2009, 14(Suppl. 1):65-73.
12. Broussard J.I., Jenson D., Dani J.A. Dopaminergic influence over hippocampal synaptic plasticity and function. Clin. Exp. Pharmacol. 2012, 2:e108.
13. Shohamy D., Adcock R.A. Dopamine and adaptive memory. Trends Cogn. Sci. 2010, 14:464-472.
14. Kumaran D., Duzel E. The hippocampus and dopaminergic midbrain: old couple, new insights. Neuron 2008, 60:197-200.
15. Fujishiro H., Umegaki H., Suzuki Y., Oohara-Kurotani S., Yamaguchi Y., Iguchi A. Dopamine D2 receptor plays a role in memory function: implications of dopamine-acetylcholine interaction in the ventral hippocampus. Psychopharmacology 2005, 182:253-261.
16. Ijomone O.M., Obi A.U. Kolaviron, isolated from Garcinia kola, inhibits acetylcholinesterase activities in the hippocampus and striatum of Wistar rats. Ann. Neurosci. 2013, 20:2-8.
17. Tripathi A., Srivastava U.C. Acetylcholinesterase: a versatile enzyme of nervous system. Ann. Neurosci. 2008, 15:106-111.
18. Chang P.L., Bhagat B., Taylor J.J. Effect of chronic administration of nicotine on acetylcholinesterase activity in the hypothalamus and medulla oblongata of the rat brain. An ultrastructural study. Brain Res. 1973, 54:75-84.
19. National Research Council of the National Academy of Sciences on Guide for the Care and Use of Laboratory Animals. Washington DC, 2011.
20. Matta S.G., Balfour D.J., Benowitz B.N., Boyd R.T., Buccafusco J.J., Caggiula A.R., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 2007, 190:269-319.
21. Scerri C. Effects of nicotine administration on amyloid precursor protein metabolism, neural cell genesis and acquisition of spatial memory. Malta Med. J. 2011, 23:66-74.
22. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Elsevier Inc., Oxford. 6th ed.
23. Takada Y., Yonezawa A., Kume T., Katsuki H., Kaneko S., Sugimoto H., Akaike A. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J. Pharmcol. Exp. Ther. 2003, 306:772-777.
24. Aosaki T., Miura M., Suzuki T., Nishimura K., Masuda M. Acetylcholine-dopamine balance hypothesis in the striatum: an update. Geriatr. Gerontol. Int. 2010, 10(Suppl. 1):S148-157.
25. Lester D.B., Rogers T.D., Blaha C.D. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci. Ther. 2010, 00:1-26.
26. Sacco K.A., Bannon K.L., George T.P. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J. Psychopharmacol. 2004, 18:457-474.
27. Quik M., Kulak J.M. Nicotine and nicotinic receptors; relevance to Parkinson's disease. Neurotoxicology 2002, 23:581-594.
28. Pohanka M. Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. Int. J. Mol. Sci. 2012, 13:2219-2238.
29. Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomed. Papers Olomouc 2011, 155:219-223.
30. Degroot A., Parent M.B. Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal gaba receptor activation on spontaneous alternation. Learn. Mem. 2000, 7:293-302.
31. Day T., Greenfield S.A. A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurons in vitro: molecular mechanisms. Neuroscience 2002, 111:649-656.
32. Ming G., Song H. Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 2005, 28:223-250.
33. Mahar I., Bagot R.C., Davoli M.A., Miksys S., Tyndale R.F., Walker C., et al. Developmental hippocampal neuroplasticity in a model of nicotine replacement therapy during pregnancy and breastfeeding. PLoS One 2012, 7:e37219.
34. Kee N., Sivalingam S., Boonstra R., Wojtowicz J.M. The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 2002, 115:97-105.
35. Mechawar N., Saghatelyan A., Grailhe R., Scoriels L., Gheusi G., Gabellec M.M., et al. Nicotinic receptors regulate the survival of newborn neurons in the adult olfactory bulb. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9822-9826.
36. Abrous D.N., Adriani W., Montaron M., Aurousseau C., Rougon G., Le Moal M., et al. Nicotine self-administration impairs hippocampal plasticity. J. Neurosci. 2002, 22:3656-3662.
37. Wei Z., Belal C., Tu W., Chigurupati S., Ameli N.J., Lu Y., Chan S.L. Chronic nicotine administration impairs activation of cyclic amp-response element binding protein and survival of newborn cells in the dentate gyrus. Stem Cells Dev. 2012, 21:411-422.
38. Campbell N.R., Fernandes C.C., Halff A.W., Berg D.K. Endogenous signaling through α7-containing nicotinic receptors promotes maturation and integration of adult born neurons in the hippocampus. J. Neurosci. 2010, 30:8734-8744.
39. Harrist A., Beech R.D., King S.L., Zanardi A., Cleary M.A., Caldarone B.J., et al. Alteration of hippocampal cell proliferation in mice lacking the beta 2 subunit of the neuronal nicotinic acetylcholine receptor. Synapse 2004, 54:200-206.